Dr Reddy's Laboratories Ltd has volunteered to withdraw 13,560 bottles of metoprolol succinate extended release tablets from the United States following the failure of dissolution tests, said the US Food and Drug Administration. The USFDA website said, "Failed dissolution specifications: failure of dissolution test observed at 18-month time point," as the reason for recall. The drug is used to prevent chest pain, medically known as angina, and ...
Read MoreYou have just read an article categorized health
titled Chest Pain Drug Withdrawn by Dr. Reddy's Laboratories From US Market.
Written by:
editor - Thursday, June 19, 2014
There are currently no comments for "Chest Pain Drug Withdrawn by Dr. Reddy's Laboratories From US Market"
Post a Comment